Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Effects of Open-label vs Double-blind Treatment in IBS [NA]
A completed clinical trial comparing open-label versus double-blind treatment in irritable bowel syndrome, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome [Phase 2, Phase 3]
A clinical trial update reports on efficacy and safety of the Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome i…
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Long Term Safety Study of Plecanatide [Phase 3]
Phase 3 long-term safety study of plecanatide in irritable bowel syndrome completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study [Phase 4]
Prospective Phase 4 study evaluating Helicobacter pylori eradication in patients with Irritable Bowel Syndrome.
-
FDA approval · 2020-07-29FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Misemer Pharmaceuticals, Inc)
FDA approved an original ANDA for chlordiazepoxide hydrochloride and clidinium bromide, a generic combination product used for GI spasms and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-07-07FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Sunrise Pharmaceutical, Inc.)
FDA approves Sunrise Pharmaceutical's original application for a generic fixed-dose combination of chlordiazepoxide hydrochloride and clidin…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome [Phase 1, Phase 2]
A completed Phase 1/2 trial studying a combination of Bifidobacterium longum 35624 and 1714 strains in adults with irritable bowel syndrome,…
-
FDA approval · 2020-05-22FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA's generic dicyclomine hydrochloride as an original ANDA product (ANDA212286).
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention [Phase 3]
Phase 3 clinical trial update investigating the frequency of sleep abnormalities in patients with Irritable Bowel Syndrome and the effect of…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating the efficacy of two probiotic strains for Irritable Bowel Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico [Phase 4]
Phase 4 clinical trial update evaluating a combination of alverine-simeticone and i3.1 probiotic for irritable bowel syndrome (IBS) in Mexic…
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome [Phase 3]
Phase 3 clinical trial evaluating ethoxysuximide and pentoxifylline for abdominal pain in irritable bowel syndrome is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating lubiprostone for adults with mixed or unsubtyped irritable bowel syndrome was terminated with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome [Phase 2]
Phase 2 clinical trial of crofelemer for diarrhea-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome [Phase 2]
Phase 2 trial update assessing the efficacy and safety of rifaximin dosed twice daily for diarrhea-associated irritable bowel syndrome has c…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Diarrhea Predominant Irritable Bowel Syndrome in Females [Phase 2]
Phase 2 clinical trial update for diarrhea-predominant irritable bowel syndrome in females.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea [Phase 2]
Phase 2 trial assessing eluxadoline (JNJ-27018966) for irritable bowel syndrome with diarrhea; results completed and posted in 2019, focusin…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Biomarkers for Intestinal Permeability in Patients With Constipation
Clinical trial update studying biomarkers for intestinal permeability in patients with constipation; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers [Phase 1]
Phase 1 first-in-human study of GSK3352589 (a RET tyrosine kinase inhibitor) in healthy volunteers; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation for diarrhea-predominant irritable bowel syndrome has completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) [Phase 3]
Phase 3 trial update for plecanatide in irritable bowel syndrome with constipation (IBS-C) completed with results posted.
-
FDA approval · 2019-04-03FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for Lotronex (alosetron hydrochloride) by Legacy Pharma USA Inc., approving a supplemental submissio…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy
The clinical trial 'Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy' sponsored by Northwell Health for Irritable Bowel Syn…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Microbiota Profiling in IBS
The clinical trial investigating microbiota profiling in irritable bowel syndrome has completed. The sponsor is Wageningen University.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS [NA]
This trial update reports on the safety and tolerability of serum-derived bovine immunoglobulin in pediatric patients with diarrhea-predomin…